Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Non-Small Cell Lung Cancer Topic Center

Featured Article

News
Real-World Data Reveal Effectiveness of Systemic Therapies for BRAF Mutation-Positive NSCLC
03/17/2023
Julie Gould
"Future studies to clarify the role of co-mutations on response to both dual-targeted BRAF/MEK inhibition and ICI-based regimens may be important to treatment selection and optimization of patient outcome," authors advised.
"Future studies to clarify the role of co-mutations on response to both dual-targeted BRAF/MEK inhibition and ICI-based regimens may be important to treatment selection and optimization of patient outcome," authors advised.
"Future studies to clarify the...
03/17/2023
First Report Managed Care
News
PD-1 Inhibitors Improve Survival in Patients With Advanced EGFR-Mutant NSCLC After TKI Resistance
03/10/2023
Jolynn Tumolo
A real-world study tested the efficacy and safety of PD-1 inhibitors for patients with non-small cell lung cancer after treatment with tyrosine kinase inhibitors failed.
A real-world study tested the efficacy and safety of PD-1 inhibitors for patients with non-small cell lung cancer after treatment with tyrosine kinase inhibitors failed.
A real-world study tested the...
03/10/2023
First Report Managed Care
News
Combination Therapy Significantly Improves PFS in Patients With NSCLC With High Tumor Mutational Burden
02/15/2023
Jolynn Tumolo
Chemoradiation and adjuvant monoclonal antibody therapy significantly improved outcomes in patients with locally advanced non-small cell lung cancer with high tumor mutational burden.
Chemoradiation and adjuvant monoclonal antibody therapy significantly improved outcomes in patients with locally advanced non-small cell lung cancer with high tumor mutational burden.
Chemoradiation and adjuvant...
02/15/2023
First Report Managed Care
News
Robotic Lobectomy Feasible for Older Adults With NSCLC, Analysis Finds
01/27/2023
Jolynn Tumolo
Researchers studied the postoperative outcomes of patients over 75 years of age who underwent a robotic-assisted lobectomy to treat non-small cell lung cancer.
Researchers studied the postoperative outcomes of patients over 75 years of age who underwent a robotic-assisted lobectomy to treat non-small cell lung cancer.
Researchers studied the...
01/27/2023
First Report Managed Care
Headshot of Nasser Altorki, MD, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Treatment Shows Disease-free Survival Benefit in Patients With NSCLC
11/09/2021
Julie Gould
Maria Asimopoulos
Nasser Altorki, MD, chief of thoracic surgery, New York Presbyterian-Weill Cornell Medicine, discusses the findings from the IMpower010 study, in which adjuvant atezolizumab resulted in a disease-free survival benefit that was superior to...
Nasser Altorki, MD, chief of thoracic surgery, New York Presbyterian-Weill Cornell Medicine, discusses the findings from the IMpower010 study, in which adjuvant atezolizumab resulted in a disease-free survival benefit that was superior to...
Nasser Altorki, MD, chief of...
11/09/2021
First Report Managed Care
Headshot of Alex Spira, Virginia Cancer Specialists Research Institute, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Treatment Options and Unmet Need in Non-small Cell Lung Cancer
10/08/2021
Maria Asimopoulos
Alex Spira, MD, PhD, FACP, director of the Virginia Cancer Specialists Research Institute, medical director at US Oncology Network, provides an overview of currently available treatment options in non-small cell lung cancer, and describes the...
Alex Spira, MD, PhD, FACP, director of the Virginia Cancer Specialists Research Institute, medical director at US Oncology Network, provides an overview of currently available treatment options in non-small cell lung cancer, and describes the...
Alex Spira, MD, PhD, FACP,...
10/08/2021
First Report Managed Care
Improving Survival Rates Among Patients With NSCLC Using New, Effective Treatment Strategy
Videos
Improving Survival Rates Among Patients With NSCLC Using New, Effective Treatment Strategy
06/18/2020
Roy S Herbst, MD, PhD, ensign professor of medicine and professor of pharmacology, chief of medical oncology, Yale Cancer Center and Smilow Cancer Hospital, discusses the results of the ADAURA study that examined the use of Tagrisso...
Roy S Herbst, MD, PhD, ensign professor of medicine and professor of pharmacology, chief of medical oncology, Yale Cancer Center and Smilow Cancer Hospital, discusses the results of the ADAURA study that examined the use of Tagrisso...
Roy S Herbst, MD, PhD, ensign...
06/18/2020
First Report Managed Care
News
Checkpoint Inhibitors To Play Major Role in Treatment of NSCLC
12/15/2017
A recent study in The Ochsner Journal examined the role of checkpoint inhibition in non–small cell lung cancer treatment. 
A recent study in The Ochsner Journal examined the role of checkpoint inhibition in non–small cell lung cancer treatment. 
A recent study in The Ochsner...
12/15/2017
First Report Managed Care
News
Recent Research Reports New Treatment Options for NSCLC
11/21/2017
Recent research, reported in The New England Journal of Medicine, showed that Tagrisso improved outcomes among non-small cell lung cancer (NSCLC) patients with an epidermal growth factor receptor.
Recent research, reported in The New England Journal of Medicine, showed that Tagrisso improved outcomes among non-small cell lung cancer (NSCLC) patients with an epidermal growth factor receptor.
Recent research, reported in The...
11/21/2017
First Report Managed Care
News
Additional NSCLC Treatments Needed to Reduce Post-Progression Costs
11/16/2017
A recent poster at AMCP Nexus 2017 found that costs during TKI treatment for Non-small cell lung cancer were similar to costs after progression, due to high hospital utilization.
A recent poster at AMCP Nexus 2017 found that costs during TKI treatment for Non-small cell lung cancer were similar to costs after progression, due to high hospital utilization.
A recent poster at AMCP Nexus...
11/16/2017
First Report Managed Care
News
Study: Tagrisso More Effective Than Chemotherapy for NSCLC
12/06/2016
Recent trial results showed that Tagrisso was more effective than chemotherapy for patients with epidermal growth factor receptor non-small cell lung cancer.
Recent trial results showed that Tagrisso was more effective than chemotherapy for patients with epidermal growth factor receptor non-small cell lung cancer.
Recent trial results showed that...
12/06/2016
First Report Managed Care

Newsfeed

News
Real-World Data Reveal Effectiveness of Systemic Therapies for BRAF Mutation-Positive NSCLC
03/17/2023
Julie Gould
"Future studies to clarify the role of co-mutations on response to both dual-targeted BRAF/MEK inhibition and ICI-based regimens may be important to treatment selection and optimization of patient outcome," authors advised.
"Future studies to clarify the role of co-mutations on response to both dual-targeted BRAF/MEK inhibition and ICI-based regimens may be important to treatment selection and optimization of patient outcome," authors advised.
"Future studies to clarify the...
03/17/2023
First Report Managed Care
News
PD-1 Inhibitors Improve Survival in Patients With Advanced EGFR-Mutant NSCLC After TKI Resistance
03/10/2023
Jolynn Tumolo
A real-world study tested the efficacy and safety of PD-1 inhibitors for patients with non-small cell lung cancer after treatment with tyrosine kinase inhibitors failed.
A real-world study tested the efficacy and safety of PD-1 inhibitors for patients with non-small cell lung cancer after treatment with tyrosine kinase inhibitors failed.
A real-world study tested the...
03/10/2023
First Report Managed Care
News
Combination Therapy Significantly Improves PFS in Patients With NSCLC With High Tumor Mutational Burden
02/15/2023
Jolynn Tumolo
Chemoradiation and adjuvant monoclonal antibody therapy significantly improved outcomes in patients with locally advanced non-small cell lung cancer with high tumor mutational burden.
Chemoradiation and adjuvant monoclonal antibody therapy significantly improved outcomes in patients with locally advanced non-small cell lung cancer with high tumor mutational burden.
Chemoradiation and adjuvant...
02/15/2023
First Report Managed Care
News
Robotic Lobectomy Feasible for Older Adults With NSCLC, Analysis Finds
01/27/2023
Jolynn Tumolo
Researchers studied the postoperative outcomes of patients over 75 years of age who underwent a robotic-assisted lobectomy to treat non-small cell lung cancer.
Researchers studied the postoperative outcomes of patients over 75 years of age who underwent a robotic-assisted lobectomy to treat non-small cell lung cancer.
Researchers studied the...
01/27/2023
First Report Managed Care
News
Checkpoint Inhibitors To Play Major Role in Treatment of NSCLC
12/15/2017
A recent study in The Ochsner Journal examined the role of checkpoint inhibition in non–small cell lung cancer treatment. 
A recent study in The Ochsner Journal examined the role of checkpoint inhibition in non–small cell lung cancer treatment. 
A recent study in The Ochsner...
12/15/2017
First Report Managed Care
News
Recent Research Reports New Treatment Options for NSCLC
11/21/2017
Recent research, reported in The New England Journal of Medicine, showed that Tagrisso improved outcomes among non-small cell lung cancer (NSCLC) patients with an epidermal growth factor receptor.
Recent research, reported in The New England Journal of Medicine, showed that Tagrisso improved outcomes among non-small cell lung cancer (NSCLC) patients with an epidermal growth factor receptor.
Recent research, reported in The...
11/21/2017
First Report Managed Care
News
Additional NSCLC Treatments Needed to Reduce Post-Progression Costs
11/16/2017
A recent poster at AMCP Nexus 2017 found that costs during TKI treatment for Non-small cell lung cancer were similar to costs after progression, due to high hospital utilization.
A recent poster at AMCP Nexus 2017 found that costs during TKI treatment for Non-small cell lung cancer were similar to costs after progression, due to high hospital utilization.
A recent poster at AMCP Nexus...
11/16/2017
First Report Managed Care
News
Study: Tagrisso More Effective Than Chemotherapy for NSCLC
12/06/2016
Recent trial results showed that Tagrisso was more effective than chemotherapy for patients with epidermal growth factor receptor non-small cell lung cancer.
Recent trial results showed that Tagrisso was more effective than chemotherapy for patients with epidermal growth factor receptor non-small cell lung cancer.
Recent trial results showed that...
12/06/2016
First Report Managed Care
News
Integrating Novel Personalized Therapy Into NSCLC Treatment
11/11/2016
Joel W Neal, MD, PhD, discussed how to integrate novel personalized therapies into non-small cell lung cancer treatment plans to optimize outcomes.
Joel W Neal, MD, PhD, discussed how to integrate novel personalized therapies into non-small cell lung cancer treatment plans to optimize outcomes.
Joel W Neal, MD, PhD, discussed...
11/11/2016
First Report Managed Care
News
Head-to-Head Trial Weighs Afatinib Versus Gefitinib for Treatment of NSCLC
04/15/2016
New data from the LUX-Lung 7 study compares outcomes with Gilotrif (afatinib, Boehringer Ingelheim Pharmaceuticals, Inc) to Iressa (gefitinib, AstraZeneca) in treatment-naïve patients with epidermal growth factor-receptor mutated...
New data from the LUX-Lung 7 study compares outcomes with Gilotrif (afatinib, Boehringer Ingelheim Pharmaceuticals, Inc) to Iressa (gefitinib, AstraZeneca) in treatment-naïve patients with epidermal growth factor-receptor mutated...
New data from the LUX-Lung 7...
04/15/2016
First Report Managed Care
News
AHA Voices Concern Over CMS Payment Updates to LTC Hospitals
08/07/2024
The American Hospital Association (AHA) expressed deep concern in response to long-term care (LTC) hospital payment updates finalized by the Centers for Medicare & Medicaid (CMS) on August 1, 2024.
The American Hospital Association (AHA) expressed deep concern in response to long-term care (LTC) hospital payment updates finalized by the Centers for Medicare & Medicaid (CMS) on August 1, 2024.
The American Hospital...
08/07/2024
First Report Managed Care
News
Obesity Linked to Distinct Heart Muscle Abnormalities in Patients With HFpEF, Study Finds
08/05/2024
A recent study published in Nature Cardiovascular Research highlighted the significant impact of severe obesity on myocardial ultrastructure in patients with heart failure with preserved ejection fraction (HFpEF), revealing potential...
A recent study published in Nature Cardiovascular Research highlighted the significant impact of severe obesity on myocardial ultrastructure in patients with heart failure with preserved ejection fraction (HFpEF), revealing potential...
A recent study published in...
08/05/2024
First Report Managed Care
News
New Treatment Options Benefit Patients With Relapsed/Refractory Follicular Lymphoma
08/05/2024
Patients with relapsed/refractory follicular lymphoma tend to have a poorer response and shortened progression-free survival with each subsequent treatment, but new treatment options are emerging.
Patients with relapsed/refractory follicular lymphoma tend to have a poorer response and shortened progression-free survival with each subsequent treatment, but new treatment options are emerging.
Patients with...
08/05/2024
First Report Managed Care
Conference Coverage
Centering Patients Within Value-Based Care
07/30/2024
Asembia 2024 speakers Olivia Banyon and Sean McCabe discuss the concept of value-based care, patient-centered care, clinician well-being, and system workflows to improve the quality of life for patients.
Asembia 2024 speakers Olivia Banyon and Sean McCabe discuss the concept of value-based care, patient-centered care, clinician well-being, and system workflows to improve the quality of life for patients.
Asembia 2024 speakers Olivia...
07/30/2024
First Report Managed Care
News
Sun Exposure Linked With Lower Risk of Follicular Lymphoma
07/30/2024
High sun exposure in warmer months may protect against the development of follicular lymphoma, according to a study published in the journal Cancer Epidemiology, Biomarkers & Prevention.
High sun exposure in warmer months may protect against the development of follicular lymphoma, according to a study published in the journal Cancer Epidemiology, Biomarkers & Prevention.
High sun exposure in warmer...
07/30/2024
First Report Managed Care
News
Updated CDC Recommendation for RSV Vaccination in Older Adults
07/29/2024
The Center for Disease Control and Prevention (CDC) vaccine advisory group updated its recommendation for the use of the respiratory syncytial virus (RSV) vaccine in older adults so that people ages 60 to 74 with certain underlying conditions...
The Center for Disease Control and Prevention (CDC) vaccine advisory group updated its recommendation for the use of the respiratory syncytial virus (RSV) vaccine in older adults so that people ages 60 to 74 with certain underlying conditions...
The Center for Disease Control...
07/29/2024
First Report Managed Care
Bill McElnea
Conference Coverage
Unlocking the Value-Based Care Potential of Health System Specialty Pharmacies
07/26/2024
Asembia 2024 speaker Bill McElnea discusses the role of health system specialty pharmacies in reducing total cost of care, enhancing medication adherence, and improving outcomes under value-based care arrangements.
Asembia 2024 speaker Bill McElnea discusses the role of health system specialty pharmacies in reducing total cost of care, enhancing medication adherence, and improving outcomes under value-based care arrangements.
Asembia 2024 speaker Bill...
07/26/2024
First Report Managed Care
News
Meta-Analysis Shows Bidirectional Link Between Psoriasis and Asthma
07/26/2024
A recent systematic review and meta-analysis spanning 12.4 million patients found a significant bidirectional association between psoriasis and asthma. Researchers published their findings online in BMC Pulmonary Medicine.
A recent systematic review and meta-analysis spanning 12.4 million patients found a significant bidirectional association between psoriasis and asthma. Researchers published their findings online in BMC Pulmonary Medicine.
A recent systematic review and...
07/26/2024
First Report Managed Care
News
HIV Cases Rise Among Gay Latinos
07/24/2024
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise...
07/24/2024
First Report Managed Care
Ashley Joseph
Conference Coverage
The Impact of AI on Infusion Patient Care and Operational Efficiency
07/22/2024
NICA 2024 session speaker Ashley Joseph of LeanTaas shares insights on how AI technologies are revolutionizing infusion therapy operations, improving care coordination, and ultimately enhancing the patient experience in these critical care...
NICA 2024 session speaker Ashley Joseph of LeanTaas shares insights on how AI technologies are revolutionizing infusion therapy operations, improving care coordination, and ultimately enhancing the patient experience in these critical care...
NICA 2024 session speaker Ashley...
07/22/2024
First Report Managed Care

Advertisement

Insights

Headshot of Nasser Altorki, MD, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Treatment Shows Disease-free Survival Benefit in Patients With NSCLC
11/09/2021
Julie Gould
Maria Asimopoulos
Nasser Altorki, MD, chief of thoracic surgery, New York Presbyterian-Weill Cornell Medicine, discusses the findings from the IMpower010 study, in which adjuvant atezolizumab resulted in a disease-free survival benefit that was superior to...
Nasser Altorki, MD, chief of thoracic surgery, New York Presbyterian-Weill Cornell Medicine, discusses the findings from the IMpower010 study, in which adjuvant atezolizumab resulted in a disease-free survival benefit that was superior to...
Nasser Altorki, MD, chief of...
11/09/2021
First Report Managed Care
Headshot of Alex Spira, Virginia Cancer Specialists Research Institute, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Treatment Options and Unmet Need in Non-small Cell Lung Cancer
10/08/2021
Maria Asimopoulos
Alex Spira, MD, PhD, FACP, director of the Virginia Cancer Specialists Research Institute, medical director at US Oncology Network, provides an overview of currently available treatment options in non-small cell lung cancer, and describes the...
Alex Spira, MD, PhD, FACP, director of the Virginia Cancer Specialists Research Institute, medical director at US Oncology Network, provides an overview of currently available treatment options in non-small cell lung cancer, and describes the...
Alex Spira, MD, PhD, FACP,...
10/08/2021
First Report Managed Care
Improving Survival Rates Among Patients With NSCLC Using New, Effective Treatment Strategy
Videos
Improving Survival Rates Among Patients With NSCLC Using New, Effective Treatment Strategy
06/18/2020
Roy S Herbst, MD, PhD, ensign professor of medicine and professor of pharmacology, chief of medical oncology, Yale Cancer Center and Smilow Cancer Hospital, discusses the results of the ADAURA study that examined the use of Tagrisso...
Roy S Herbst, MD, PhD, ensign professor of medicine and professor of pharmacology, chief of medical oncology, Yale Cancer Center and Smilow Cancer Hospital, discusses the results of the ADAURA study that examined the use of Tagrisso...
Roy S Herbst, MD, PhD, ensign...
06/18/2020
First Report Managed Care
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Owens
Podcasts
Understanding the Impact of Formulary Exclusions on Medication Adherence
03/28/2024

Featuring Gary Owens, MD, president of Gary Owens Associates

Featuring Gary Owens, MD, president o...
Join us as guest expert Gary Owens discusses how formulary exclusions can impact patient medication adherence and lead to adverse economic outcomes, making the need for non-medical switching and formulary exception requests an important issue...
Join us as guest expert Gary Owens discusses how formulary exclusions can impact patient medication adherence and lead to adverse economic outcomes, making the need for non-medical switching and formulary exception requests an important issue...
Join us as guest expert Gary...
03/28/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Prajapati Podcast
Podcasts
Standardizing the Field of Digital Medicine: Insights from an Industry Expert
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates Consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates Consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement